Clinical Trial Update: A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating chemoradiotherapy with SHR-1316 for locally advanced cervical cancer. The study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• SHR-1316

Snippet

Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd | Conditions: Locally Advanced Cervical Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING